Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new page revision v3.6.5 was added to the study record history, replacing the prior v3.6.4 entry.
    Difference
    0.1%
    Check dated 2026-08-08T22:20:32.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The history log now includes a new revision entry v3.6.4. The previous v3.6.3 entry has been replaced, signaling an update to the study record's versioning.
    Difference
    0.1%
    Check dated 2026-07-25T13:21:59.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.3) was added to the study history, replacing the previous revision (v3.6.2) and updating the record's documentation.
    Difference
    0.1%
    Check dated 2026-07-04T03:50:07.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The history shows a new revision tag v3.6.2 was added and v3.6.0 removed, representing an administrative update to the record rather than substantive changes to the trial.
    Difference
    0.1%
    Check dated 2026-06-26T23:31:52.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Recruitment status updated to No longer looking for participants. The history also shows a new Revision: v3.6.0 and the removal of the previous Revision: v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-12T15:34:02.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Version bumped in the site footer from v3.5.4 to v3.5.5, signaling a new deployment of the ClinicalTrials.gov interface. No user-facing content changes are indicated by this update.
    Difference
    0.1%
    Check dated 2026-06-05T10:23:14.000Z thumbnail image

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.